3/11
07:21 am
gh
Guardant Health Receives ADLT Status From CMS for Shield Blood Test [Yahoo! Finance]
High
Report
Guardant Health Receives ADLT Status From CMS for Shield Blood Test [Yahoo! Finance]
3/11
07:00 am
gh
Guardant Health Receives ADLT Status From CMS for Shield Blood Test
High
Report
Guardant Health Receives ADLT Status From CMS for Shield Blood Test
3/6
12:37 pm
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Morgan Stanley from $42.00 to $52.00. They now have an "overweight" rating on the stock.
Low
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Morgan Stanley from $42.00 to $52.00. They now have an "overweight" rating on the stock.
3/5
08:34 am
gh
Guardant Health Joins Forces With Dak Prescott's Faith Fight Finish Foundation and Feist-Weiller Cancer Center's Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities [Yahoo! Finance]
Low
Report
Guardant Health Joins Forces With Dak Prescott's Faith Fight Finish Foundation and Feist-Weiller Cancer Center's Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities [Yahoo! Finance]
3/5
08:05 am
gh
Guardant Health Joins Forces With Dak Prescott’s Faith Fight Finish Foundation and Feist-Weiller Cancer Center’s Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities
Low
Report
Guardant Health Joins Forces With Dak Prescott’s Faith Fight Finish Foundation and Feist-Weiller Cancer Center’s Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities
3/3
03:45 pm
gh
Guardant Health's (NASDAQ:GH) Q4: Beats On Revenue [Yahoo! Finance]
Neutral
Report
Guardant Health's (NASDAQ:GH) Q4: Beats On Revenue [Yahoo! Finance]
2/28
05:05 pm
gh
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/27
08:32 am
gh
New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change [Yahoo! Finance]
Medium
Report
New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change [Yahoo! Finance]
2/27
08:05 am
gh
New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change
Low
Report
New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change
2/26
01:31 pm
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Piper Sandler from $34.00 to $50.00. They now have an "overweight" rating on the stock.
Low
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Piper Sandler from $34.00 to $50.00. They now have an "overweight" rating on the stock.
2/26
12:17 pm
gh
Guardant Health (GH): Among the Best Performing Mid Cap Stocks to Buy According to Analysts [Yahoo! Finance]
Neutral
Report
Guardant Health (GH): Among the Best Performing Mid Cap Stocks to Buy According to Analysts [Yahoo! Finance]
2/25
02:24 pm
gh
Guardant accuses Natera of poaching employees, stealing trade secrets [Yahoo! Finance]
Low
Report
Guardant accuses Natera of poaching employees, stealing trade secrets [Yahoo! Finance]
2/24
10:19 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Scotiabank from $47.00 to $52.00. They now have a "sector outperform" rating on the stock.
Low
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Scotiabank from $47.00 to $52.00. They now have a "sector outperform" rating on the stock.
2/24
10:19 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $56.00 price target on the stock.
Low
Report
Guardant Health, Inc. (NASDAQ: GH) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $56.00 price target on the stock.
2/24
08:16 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Canaccord Genuity Group Inc. from $42.00 to $60.00. They now have a "buy" rating on the stock.
Low
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Canaccord Genuity Group Inc. from $42.00 to $60.00. They now have a "buy" rating on the stock.
2/21
03:26 pm
gh
Guardant Health files lawsuit against Natera for stealing trade secrets [Seeking Alpha]
Low
Report
Guardant Health files lawsuit against Natera for stealing trade secrets [Seeking Alpha]
2/21
12:41 pm
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $49.00 to $56.00. They now have a "buy" rating on the stock.
Low
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $49.00 to $56.00. They now have a "buy" rating on the stock.
2/21
12:01 pm
gh
Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
Low
Report
Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
2/21
12:01 pm
gh
Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
2/21
12:01 pm
gh
Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
2/21
11:10 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $59.00 price target on the stock, up previously from $39.00.
Medium
Report
Guardant Health, Inc. (NASDAQ: GH) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $59.00 price target on the stock, up previously from $39.00.
2/21
10:16 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $55.00. They now have an "overweight" rating on the stock.
Medium
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $55.00. They now have an "overweight" rating on the stock.
2/21
09:53 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Stifel Nicolaus from $45.00 to $53.00. They now have a "buy" rating on the stock.
Medium
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target raised by analysts at Stifel Nicolaus from $45.00 to $53.00. They now have a "buy" rating on the stock.
2/20
11:16 pm
gh
https://seekingalpha.com/article/4760533-guardant-health-inc-gh-q4-2024-earnings-call-transcript [Seeking Alpha]
Medium
Report
https://seekingalpha.com/article/4760533-guardant-health-inc-gh-q4-2024-earnings-call-transcript [Seeking Alpha]
2/20
07:17 pm
gh
Guardant Health: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Guardant Health: Q4 Earnings Snapshot [Yahoo! Finance]